These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 27234306)
21. Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia. Stapf M; Pömpner N; Teichgräber U; Hilger I Int J Nanomedicine; 2016; 11():485-500. PubMed ID: 26893557 [TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo evaluation of sandwich-like mesoporous silica nanoflakes as promising anticancer drug delivery system. Peruzynska M; Szelag S; Trzeciak K; Kurzawski M; Cendrowski K; Barylak M; Roginska D; Piotrowska K; Mijowska E; Drozdzik M Int J Pharm; 2016 Jun; 506(1-2):458-68. PubMed ID: 27032563 [TBL] [Abstract][Full Text] [Related]
23. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications. Tahir N; Madni A; Balasubramanian V; Rehman M; Correia A; Kashif PM; Mäkilä E; Salonen J; Santos HA Int J Pharm; 2017 Nov; 533(1):156-168. PubMed ID: 28963013 [TBL] [Abstract][Full Text] [Related]
24. Sequential combination chemotherapy in human breast cancer: a basis for increased antineoplastic activity and bone marrow protection. Davis JH; Desoto JA; Fryar EB; Southerland WM; Bowen D Cell Mol Biol (Noisy-le-grand); 2007 May; 53(3):18-26. PubMed ID: 17531145 [TBL] [Abstract][Full Text] [Related]
25. Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo-photothermal therapy. Nguyen HT; Phung CD; Thapa RK; Pham TT; Tran TH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO Acta Biomater; 2018 Mar; 68():154-167. PubMed ID: 29292170 [TBL] [Abstract][Full Text] [Related]
26. Lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate. Kurmi BD; Gajbhiye V; Kayat J; Jain NK J Pharm Sci; 2011 Jun; 100(6):2311-20. PubMed ID: 21491447 [TBL] [Abstract][Full Text] [Related]
27. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer. Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abulsamad K; Adams SL Clin Immunol; 2008 Aug; 128(2):205-18. PubMed ID: 18511346 [TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of methotrexate-loaded microcapsules. Genç L; Büyüktıryakı S Pharm Dev Technol; 2014 Feb; 19(1):42-7. PubMed ID: 23368981 [TBL] [Abstract][Full Text] [Related]
29. Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model. Garg NK; Singh B; Tyagi RK; Sharma G; Katare OP Colloids Surf B Biointerfaces; 2016 Nov; 147():17-24. PubMed ID: 27478959 [TBL] [Abstract][Full Text] [Related]
30. Sequence- and time-dependent antagonism between raloxifene and methotrexate in human breast cancer cells. De Soto JA; Bowen D; Davis JH; Southerland WM; Hawkins M Anticancer Res; 2002; 22(2A):1007-9. PubMed ID: 12014617 [TBL] [Abstract][Full Text] [Related]
31. Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate. Salehi R; Rasouli S; Hamishehkar H Int J Pharm; 2015 Jun; 487(1-2):274-84. PubMed ID: 25895723 [TBL] [Abstract][Full Text] [Related]
32. A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis. Abolmaali SS; Tamaddon AM; Dinarvand R Cancer Chemother Pharmacol; 2013 May; 71(5):1115-30. PubMed ID: 23292116 [TBL] [Abstract][Full Text] [Related]
33. Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers. Subia B; Kundu SC Nanotechnology; 2013 Jan; 24(3):035103. PubMed ID: 23262833 [TBL] [Abstract][Full Text] [Related]
34. Raloxifene attenuation of 5-FU/methotrexate cytotoxicity in human breast cancer cells: the importance of sequence in combination chemotherapy. Fryar EB; Das JR; Davis JH; Desoto JA; Laniyan I; Southerland WM; Bowen D Anticancer Res; 2006; 26(3A):1861-7. PubMed ID: 16827118 [TBL] [Abstract][Full Text] [Related]
35. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate. Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804 [TBL] [Abstract][Full Text] [Related]
36. 5-Fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity in human bone marrow. Bowen D; Johnson DH; Southerland WM; Hughes DE; Hawkins M Anticancer Res; 1999; 19(2A):985-8. PubMed ID: 10368642 [TBL] [Abstract][Full Text] [Related]
37. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy. Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702 [TBL] [Abstract][Full Text] [Related]
38. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment. Hu G; Chun X; Wang Y; He Q; Gao H Oncotarget; 2015 Dec; 6(38):41258-74. PubMed ID: 26517810 [TBL] [Abstract][Full Text] [Related]
39. Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy. Ferreira M; Chaves LL; Lima SA; Reis S Int J Pharm; 2015 Aug; 492(1-2):65-72. PubMed ID: 26169145 [TBL] [Abstract][Full Text] [Related]
40. Synthetic polyglutamylation of dual-functional MTX ligands for enhanced combined cytotoxicity of poly(I:C) nanoplexes. Lächelt U; Wittmann V; Müller K; Edinger D; Kos P; Höhn M; Wagner E Mol Pharm; 2014 Aug; 11(8):2631-9. PubMed ID: 24754871 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]